Cadrenal Therapeutics Inc (CVKD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2017 | |
| Operating Expenses | 10,961 | 7,633 | 2,702 | 0 |
| Operating Income | -10,961 | -7,633 | -2,702 | N/A |
| Interest Expense | 0 | 17 | 107 | 0 |
| Other Income | 309 | -707 | -3,906 | 0 |
| Pre-tax Income | -10,651 | -8,357 | -6,714 | 0 |
| Net Income Continuous | -10,651 | -8,357 | -6,714 | N/A |
| Net Income | $-10,651 | $-8,357 | $-6,714 | $N/A |
| EPS Basic Total Ops | -8.73 | -9.29 | -12.74 | N/A |
| EPS Basic Continuous Ops | -8.73 | -9.29 | -12.76 | N/A |
| EPS Diluted Total Ops | -8.73 | -9.29 | -12.74 | N/A |
| EPS Diluted Continuous Ops | -8.73 | -9.29 | -12.76 | N/A |
| EPS Diluted Before Non-Recurring Items | -8.73 | -8.25 | N/A | N/A |
| EBITDA(a) | $-10,959 | $-7,617 | $-2,633 | $N/A |